Pharmacological mechanisms of T3 augmentation of antidepressant action

International Journal of Neuropsychopharmacology

Volumn 3, Issue 2, 2000, Pages 187-191

  Newman, Michael E ^a   Agid, Ofer ^a   Gur, Eitan ^a   Lerer, Bernard ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Antidepressant; Noradrenaline; Serotonin; Triiodothyronine

Indexed keywords

ANTIDEPRESSANT AGENT; CELL NUCLEUS RECEPTOR; LIOTHYRONINE; MEMBRANE RECEPTOR;

ARTICLE; DEPRESSION; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SEROTONINERGIC SYSTEM;

EID: 0033916754     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145700001875     Document Type: Article

References (31)

1. Baumgartner A, Hiedra L, Pinna G, Eravci M, Prengel H, Mainhold H (1998). Rat brain II 5′-iodothyronine deiodinase activity is extremely sensitive to stress. Journal of Neurochemistry 71, 817-826.
2. Blier P, de Montigny C (1994). Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences 15, 220-226.
3. Campos-Barros A, Musa A, Flechner A, Hessenius C, Gaio U, Meinhold H, Baumgartner A (1997). Evidence for circadian variations of thyroid hormone concentrations and type II 5′-iodothyronine deiodinase activity in the rat central nervous system. Journal of Neurochemistry 68, 795-803.
4. Cleare AJ, McGregor A, Chambers SM, Dawling S, O'Keane V (1996). Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism. Neuroendocrinology 64, 65-69.
5. Cleare AJ, McGregor A, O'Keane V (1995). Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clinical Endocrinology 43, 713-719.
6. Dratman MB, Gordon JT (1996). Thyroid hormones as neurotransmitters. Thyroid 6, 639-647.
7. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Archives of General Psychiatry 54, 597-606.
8. 3H]-cAMP production in slices of rat cerebral cortex. Neuropharmacology 13, 1131-1140.
9. Gordon JT, Kaminski DM, Rozanov CB, Dratman MB (1999). Evidence that 3,3′,5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradenergic targets via anterograde axonal transport. Neuroscience 93, 943-954.
10. Gross G, Brodde O-E, Schumann HJ (1980). Effects of thyroid hormone deficiency on pre-and postsynaptic noradrenergic mechanisms in the rat cerebral cortex. Archives of International Pharmacodynamics 244, 219-230.
11. Gur E, Lerer B, Newman ME (1999). Chronic clomipramine and triiodothyronine increase 5-HT levels in rat frontal cortex in vivo: relationship to 5-HT autoreceptor activity. Journal of Pharmacology and Experimental Therapeutics 288, 81-87.
12. Heal DJ, Smith SL (1988). The effects of acute and repeated administration of T3 to mice on 5-HT-1 and 5-HT-2 function in the brain and its influence on the actions of repeated electroconvulsive shock. Neuropharmacology 27, 1239-1248.
13. Henley WN, Bellush LL (1992). Streptozotocin-induced decreases in serotonin turnover are prevented by thyroidectomy. Neuroendocrinology 56, 3554-3363.
14. Henley WN, Koehnle TJ (1997). Thyroid hormones and the treatment of depression: an examination of basal hormonal actions in the mature mammalian brain. Synapse 27, 36-44.
15. Kamiliaris TC, DeBold CR, Pavlou SN, Island DP, Hoursanidis A, Orth DN (1987). Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. Journal of Clinical Endocrinology and Metabolism 65, 994-999.
16. 2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain. Neuroendocrinology 69, 453-459.
17. Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B (1992). Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Research 43, 137-146.
18. Mason GA, Bondy SC, Nemeroff CB, Walker CH, Prange AJ (1987). The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain. Psychoneuroendocrinology 12, 261-270.
19. Mazurkiewicz D, Saggerson ED (1989). Inhibition of adenylate cyclase in rat brain synaptosomal membranes by GTP and phenylisopropyladenosine is enhanced in hypothyroidism. Biochemical Journal 263, 829-835.
20. Newman ME, Shapira B, Lerer B (1998). Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. International Journal of Neuropsychopharmacology 1, 49-69.
21. Orford M, Leung FCL, Milligan G, Saggerson ED (1992). Treatment with triiodothyronine decreases the abundance of the α-subunits of Gi1 and Gi2 in the cerebral cortex. Journal of Neurological Sciences 122, 34-37.
22. Rastogi RB, Singhal RL (1976). Influence of neonatal and adult hyperthyroidism on behaviour and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in the rat brain. Journal of Pharmacology and Experimental Therapeutics 198, 609-618.
23. Sandrini M, Vitale G, Vergoni AV, Ottani A, Bertolini A (1996). Effect of acute and chronic treatment with triiodothyronirie on serotonin levels and serotonergic receptor subtypes in the rat brain. Life Sciences 58, 1551-1559.
24. Schmidt BH, Schulz JE (1985). Chronic thyroxine treatment of rats down-regulates the noradrenergic cyclic AMP generating system in cerebral cortex. Journal of Pharmacology and Experimental Therapeutics 233, 466-472.
25. Shapira B, Lerer B, Kindler S, Lichtenberg P, Gropp C, Cooper TB, Calev A (1992a). Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression. British Journal of Psychiatry 160, 223-229.
26. Shapira B, Reiss A, Kindler S, Lerer B (1989). Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. Journal of Affective Disorders 16, 1-4.
27. Shapira B, Yagmur MJ, Gropp C, Newman ME, Lerer B (1992b). Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression. Biological Psychiatry 31, 975-983.
28. Swann AC (1988). Thyroid hormone and norepinephrine: effects on alpha-2, beta, and reuptake sites in cerebral cortex and heart. Journal of Neural Transmission 71, 195-205.
29. Tejani-Butt SM, Yang J, Kaviani A (1993). Time course of altered thyroid states on 5-HT1A receptors and 5-HT uptake sites in rat brain: an autoradiographic analysis. Neuroendocrinology 57, 1011-1018.
30. Vaccari A (1982). Decreased central serotonin function in hypothyroidism. European Journal of Pharmacology 82, 93-95.
31. Whybrow PC, Prange AJ (1981). A hypothesis of thyroid-catecholamine-receptor interaction: its relevance to affective illness. Archives of General Psychiatry 38, 106-113.